Skip to main content

and
  1. Article

    Open Access

    Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD)

    Patients with COPD are often affected by loss of bone mineral density (BMD) and osteoporotic fractures. Natriuretic peptides (NP) are known as cardiac markers, but have also been linked to fragility-associated...

    Franziska C. Trudzinski, Rudolf A. Jörres, Peter Alter, Henrik Watz in Respiratory Research (2024)

  2. Article

    Open Access

    Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET

    Randomized controlled trials described beneficial effects of inhaled triple therapy (LABA/LAMA/ICS) in patients with chronic obstructive pulmonary disease (COPD) and high risk of exacerbations. We studied whet...

    Jennifer A. Zader, Rudolf A. Jörres, Imke Mayer, Peter Alter in BMC Pulmonary Medicine (2024)

  3. Article

    Open Access

    Tumor seeding following CT- guided transthoracic needle biopsy in lung cancer. A case report

    As a result of advances in the treatment of lung cancer, the life expectancy of lung cancer patients has improved significantly, but it remains the leading cause of cancer death worldwide. For decades, most of...

    Thomas Melzer, Caroline Maria Hackl, Julia Walter, Jürgen Behr in BMC Pulmonary Medicine (2023)

  4. Article

    Open Access

    Consequences of the COVID-19 pandemic on lung cancer care and patient health in a German lung cancer center: results from a cross-sectional questionnaire

    The novel coronavirus SARS-CoV-2 has caused a global COVID-19 pandemic, leading to worldwide changes in public health measures. In addition to changes in the public sector (lockdowns, contact restrictions), ho...

    Julia Walter, Laura Sellmer, Kathrin Kahnert, Rosemarie Kiefl in Respiratory Research (2022)

  5. Article

    Open Access

    Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET

    Lung emphysema is an important phenotype of chronic obstructive pulmonary disease (COPD), and CT scanning is strongly recommended to establish the diagnosis. This study aimed to identify criteria by which phys...

    Christina Kellerer, Rudolf A. Jörres, Antonius Schneider in Respiratory Research (2021)

  6. Article

    Open Access

    Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort

    Forced expiratory volume in one second (FEV1) characterizes the pathophysiology of COPD and different trajectories of FEV1 decline have been observed in patients with COPD (e.g. gradual or episodic). There is lim...

    Johanna I. Lutter, Rudolf A. Jörres, Kathrin Kahnert in BMC Pulmonary Medicine (2020)

  7. Article

    Open Access

    The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort

    Alterations of cognitive functions have been described in COPD. Our study aimed to disentangle the relationship between the degree of cognitive function and COPD characteristics including quality of life (QoL).

    Sarah Marietta von Siemens, Robert Perneczky, Claus F. Vogelmeier in Respiratory Research (2019)

  8. Article

    Open Access

    Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD

    COPD influences cardiac function and morphology. Changes of the electrical heart axes have been largely attributed to a supposed increased right heart load in the past, whereas a potential involvement of the l...

    Peter Alter, Henrik Watz, Kathrin Kahnert, Klaus F. Rabe in Respiratory Research (2019)

  9. Article

    Open Access

    Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study

    The diagnosis of depression, a frequent comorbidity of chronic obstructive pulmonary disease (COPD), is often supported by questionnaires, such as the Patient Health Questionnaire 9 (PHQ-9). It is unknown to w...

    Sarah Marietta von Siemens, Rudolf A. Jörres, Jürgen Behr in Respiratory Research (2019)

  10. Article

    Open Access

    Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation

    There is a need for non-invasive parameters that are sensitive to the development of the bronchiolitis obliterans syndrome (BOS) in lung transplantation (LTx) patients. We studied whether the pulmonary diffusi...

    Anna Winkler, Kathrin Kahnert, Jürgen Behr, Claus Neurohr in Respiratory Research (2018)

  11. Article

    Open Access

    Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach

    Recent investigations showed single associations between uric acid levels, functional parameters, exacerbations and mortality in COPD patients. The aim of this study was to describe the role of uric acid withi...

    Kathrin Kahnert, Peter Alter, Tobias Welte, Rudolf M. Huber in Respiratory Research (2018)

  12. Article

    Open Access

    Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort

    An impairment of CO diffusing capacity has been shown in diabetic patients without lung disease. We analyzed how diffusing capacity in patients with COPD is affected by the concurrent diagnosis of diabetes.

    Kathrin Kahnert, Tanja Lucke, Frank Biertz, Andreas Lechner in Respiratory Research (2017)